Gilead Sciences Inc buy RudolfL
Start price
09.01.21
/
60%
€51.89
Target price
09.01.22
€68.00
Performance (%)
8.15%
End price
30.10.21
€56.12
Summary
This prediction ended on 30.10.21 with a price of €56.12. The BUY prediction by RudolfL finished with a performance of 8.15%. A total of €1.78 was paid as dividends for this prediction. RudolfL has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gilead Sciences Inc | -1.171% | -1.171% | 3.945% | 22.224% |
iShares Core DAX® | 1.518% | 3.456% | 25.970% | 21.597% |
iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% | 39.177% |
iShares Nikkei 225® | 2.808% | 2.743% | 19.597% | 5.115% |
iShares S&P 500 | 0.403% | 2.187% | 28.624% | 40.348% |
According to RudolfL what are the pros and cons of Gilead Sciences Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Undervalued
EBIT growth >5% per year expected
Cons
Comments by RudolfL for this prediction
In the thread Gilead Sciences Inc diskutieren
Buy mit Kursziel 57,0
Kursziel geändert auf 68,0
In the thread Trading Gilead Sciences Inc
Buy beendet
Stopped prediction by RudolfL for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.96
02.01.24
02.01.24
€80.00
02.02.24
02.02.24
-6.29%
22.01.24
22.01.24
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€75.86
04.11.23
04.11.23
€89.00
04.12.23
04.12.23
-4.82%
05.12.23
05.12.23
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€64.70
22.02.20
22.02.20
€82.00
14.05.20
14.05.20
10.82%
14.05.20
14.05.20
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital